Theophylline sodium glycinate

甘氨酸茶碱钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTheophylline sodium glycinate
Drug Alias NameAsbron
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsPulmonary EdemaLung DiseasesAsthma +[4] 
Global Approved IndicationsPulmonary EdemaAsthmaBronchitis
Approved Indications in ChinaPulmonary EdemaAsthmaBronchitis
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesDandong Medical Innovation Pharmaceutical Co Ltd
Inactive CompaniesNational Heart, Lung, And Blood Institute (Nhlbi)
Active IndicationsPulmonary EdemaAsthmaBronchitis
Inactive IndicationsLung Diseases

Other Information

ATC CodeR03DA04
Related LinksDrugBankKEGG